SelectQuote (SLQT) Q1 2027 Earnings Call Transcript

SelectQuote (SLQT) reported a Q1 2027 adjusted EBITDA loss of $17M, improved from last year. Revenue was $280M, down 15% YoY. Senior segment lost $12M (improved $9M YoY), while Healthcare Services EBITDA rose 56% YoY to $11M. The company reiterated its fiscal 2027 operating cash flow target of at least $60M, citing strong profitability and cash flow performance.

Original reporting
Published Nov 4, 2026, 7:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 7:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SelectQuote (SLQT) Q1 2027 Earnings Call Transcript — source image
Decision brief

The 30-second read

$SLQTBearishMed
01

Why it matters

The disclosed revenue decline and loss may trigger short‑term price weakness, while operational improvements and AI initiatives could support longer‑term upside.

02

Market read

First‑time disclosure of Q1 numbers for SLQT; investors will reassess growth outlook and cost structure.

03

What to watch

Cost‑cutting measures and AI‑driven efficiency gains may boost margins in later quarters, offsetting short‑term revenue headwinds.

Relevance 7/10Novelty 7/10Timing: after-hours release

Background

SelectQuote (SLQT) provided its Q1 2027 earnings call transcript, detailing financial performance, segment results, and strategic initiatives.

Company-level read

Ticker impact

$SLQTBearishHigh confidence
Context

Q1 2027 earnings call disclosed adjusted EBITDA loss of $17M, revenue $280M, a 15% YoY decline and segment improvements.

Expected impact

likely downward pressure as investors digest lower revenue and loss, despite EBITDA improvement.

Evidence & confidence

The transcript provides the first public release of Q1 numbers, showing a revenue decline and loss, which typically triggers sell‑side reaction.

Market effects

Highlights pressure on Medicare Advantage and health‑insurance distributors, may affect peers in the senior‑care benefits space.

U.S. health‑services sector could see modest pullback.

Limited to U.S. health‑insurance market; no broader macro impact.

Counterpoint

The EBITDA loss improvement and AI/technology investments could position SLQT for upside if the market overreacts to revenue decline.

Key entities

  • SelectQuote

    U.S. health‑insurance distributor reporting Q1 2027 results.

Related articles

$SLQTMed

SelectQuote Inc (SLQT) (Q1 2027) Earnings Call Highlights: Beats EBITDA and Cash Flow

SelectQuote Inc (SLQT) reported Q1 2027 earnings, beating EBITDA and cash flow estimates. President Bob noted stable plan termination and high beneficiary engagement. CFO Ryan Clement highlighted progress toward a $60M operating cash flow target, with potential future cash dividends. CEO Tim Danker mentioned strong front-end production and improved recapture rates. The company is expanding its Olathe facility and investing in technology for other sites.

$SLQTMedAI 8/10

SelectQuote places fewer Medicare policies but earns more on each one

SelectQuote (SLQT) approved 18% fewer Medicare Advantage policies in Q1 2027, with revenue falling to $280M from $329M. However, commission values per policy rose 16% to $890. The company is shrinking its agent force to improve efficiency, and adjusted EBITDA losses narrowed. Healthcare Services revenue fell 16% but adjusted EBITDA rose 56%. SelectQuote maintained its full-year guidance and faces a False Claims Act lawsuit.

$SLQTMed

What SelectQuote (SLQT) Said on Its Q1 Earnings Call

SelectQuote (SLQT) reported Q1 earnings, with Senior revenue declining to $51M from $59M, but adjusted EBITDA loss narrowing. Healthcare Services revenue fell to $186M, while adjusted EBITDA rose 56% to $11M. Life Insurance revenue declined to $43M, but adjusted EBITDA increased 31% to $7M. The company plans a reverse stock split and invests in AI and technology. Management noted stability in commissions and potential carrier marketing efforts.

$SLQTMedAI 8/10

SelectQuote (SLQT) Q1 2027 Earnings Call Transcript

SelectQuote (SLQT) reported Q1 2027 revenue of $280M, down 15% YoY, with an adjusted EBITDA loss of $17M. Senior revenue fell 14% YoY, while Medicare Advantage policies decreased 18%. Healthcare Services revenue dropped 16%, but EBITDA grew 56%. The company maintained full-year guidance and plans a reverse stock split. Management prioritized profitability over volume, leveraging AI and operational efficiencies.

Med

SelectQuote, Inc. Q1 2027 Earnings Call Summary

SelectQuote reported a $15M year-over-year adjusted EBITDA gain in Q1 2027, driven by a focus on profitability over volume. Healthcare Services margins increased 60% through member base optimization. Revenue declines in the Senior segment were planned. Management expects $60M operating cash flow in fiscal 2027 and a path to cash-paying preferred dividends by fiscal 2028. The Inflation Reduction Act impacted revenue but was offset by reimbursements.